Hydrolytic fate of deoxynivalenol-3-glucoside during digestion  by Berthiller, Franz et al.
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Deoxynivalenol-3--d-glucoside  (D3G),  a  plant  phase  II  metabolite  of  the  Fusarium  mycotoxin  deoxyni-
valenol  (DON),  occurs  in  naturally  contaminated  wheat,  maize,  oat, barley  and  products  thereof.  Although
considered  as  a  detoxiﬁcation  product  in  plants,  the  toxicity  of  this  substance  in  mammals  is currently
unknown.  A  major  concern  is the possible  hydrolysis  of  the  D3G  conjugate  back  to  its  toxic  precursor
mycotoxin  DON  during  mammalian  digestion.  We  used  in  vitro  model  systems  to investigate  the  stability
of  D3G  to acidic  conditions,  hydrolytic  enzymes  and  intestinal  bacteria,  mimicking  different  stages  of
◦
eoxynivalenol-3-glucoside
eoxynivalenol
onjugated mycotoxins
asked mycotoxins
igestion
digestion.  D3G  was  found  resistant  to  0.2  M  hydrochloric  acid for  at least  24  h  at  37 C, suggesting  that
it  will  not  be hydrolyzed  in  the  stomach  of  mammals.  While  human  cytosolic  -glucosidase  also  had
no  effect,  fungal  cellulase  and  cellobiase  preparations  could  cleave  a signiﬁcant  portion  of  D3G.  Most
importantly,  several  lactic  acid  bacteria  such  as Enterococcus  durans,  Enterococcus  mundtii  or Lactobacillus
plantarum  showed  a high  capability  to  hydrolyze  D3G.  Taken  together  these  data  indicate  that  D3G  is of
d  shydrolysis toxicological  relevance  an
. Introduction
Deoxynivalenol (DON) is a Fusarium mycotoxin, belonging to
he class of trichothecenes (e.g. reviewed by JECFA, 2001). A more
ecent review discusses the mechanisms of action, human exposure
nd toxicological relevance of this substance (Pestka, 2010). In brief,
ON inhibits eucaryotic protein synthesis and alters cell signal-ng, differentiation and proliferation, which will ultimately result
n cellular death. DON can often be found in cereal-based food and
eed, and is therefore regulated by several countries. For instance
Abbreviations: D3G, deoxynivalenol-3-glucoside; DON, deoxynivalenol; JECFA,
oint  FAO/WHO Expert Committee on Food Additives; ZEN, zearalenone; Z-14-G,
earalenone-14--d-glucoside; HPLC, high performance liquid chromatography;
S,  mass spectrometry; MS/MS, tandem mass spectrometry; EDTA, ethylene-
iaminetetraacetic acid; EC, Enzyme Commission number; DSMZ, Deutsche
ammlung von Mikroorganismen und Zellkulturen; ATCC, American Type Culture
ollection; LMG, Laboratorium voor Microbiologie; ESI, electrospray ionization;
AD, collision activated dissociation; MRM,  multiple reaction monitoring; DP,
eclustering potential; CE, collision energy; hCBG, human cytosolic -glucosidase.
∗ Corresponding author. Tel.: +43 2272 66280 413; fax: +43 2272 66280 403.
E-mail address: franz.berthiller@boku.ac.at (F. Berthiller).
378-4274 © 2011 Elsevier Ireland Ltd. 
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Open access under CC BY-NC-ND license.ould  be regarded  as  a masked  mycotoxin.
© 2011 Elsevier Ireland Ltd. 
in Europe, maximum levels depend on the foodstuff itself as well
as the intended purpose and range from 200 g/kg for processed
cereal-based food or babyfood up to 1750 g/kg for unprocessed
durum wheat, oats and maize (EC Regulation No 1126/2007).
Glucosylation, a reaction occurring in phase II metabolism of
plants, represents a major route to detoxify xenobiotics (reviewed
in Bowles et al., 2006). Phase II conjugates can either be incorpo-
rated into the insoluble fraction of the plant cell wall (phase III
metabolism) or converted into a soluble form and transferred into
plant cell vacuoles. Experiments with radiolabeled mycotoxins in
maize cell suspension cultures indicated that around 10% of the ini-
tial radioactivity of 14C-DON was incorporated as insoluble “bound
residue” in the plant matrix (Engelhardt et al., 1999). Although the
bioavailability rates of mycotoxins from bound residues are largely
unexplored, DON bound residues seem to be of limited toxicological
relevance.
The situation might be entirely different for the soluble DON-3-
-d-glucoside (D3G, Fig. 1), which is formed from DON in Fusarium
Open access under CC BY-NC-ND license.infected plants and stored in the vacuole. Such a glucose conjugate
of DON was  already postulated in the eighties (Miller et al., 1983;
Young et al., 1984). Later, it was  possible to verify the structure of
this conjugate as D3G, which was  chemically synthesized (Savard,
F. Berthiller et al. / Toxicology Let
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Fig. 1. Structure of deoxynivalenol-3-glucoside.
991) and isolated from DON treated maize cell suspension cultures
Sewald et al., 1992). For the ﬁrst time, we reported the occurrence
f D3G in naturally contaminated wheat and maize (Berthiller et al.,
005). Sasanya et al. (2008) showed that the mean concentrations of
3G in selected hard red spring wheat samples exceeded the mean
ON concentrations. D3G was also found in naturally contaminated
arley as well as in malt (Lancova et al., 2008) and beer (Kostelanska
t al., 2009) made thereof. We  studied the occurrence of D3G in
aturally contaminated cereals (Berthiller et al., 2009a), showing
hat over 30% of the extractable total DON can be present as D3G
n maize. Recently, D3G was also detected in oats to a level similar
o that in other cereals (Desmarchelier and Seefelder, 2011). The
orldwide occurrence of D3G was conﬁrmed after identiﬁcation of
3G in Chinese wheat and maize samples in the same concentration
ange as DON (Li et al., 2011).
D3G is far less active as protein biosynthesis inhibitor than DON,
s demonstrated with wheat ribosomes in vitro (Poppenberger
t al., 2003). The glucosylation reaction is therefore considered
 detoxiﬁcation of DON in plants. Wheat lines which are able to
ore efﬁciently convert DON to D3G, are more resistant towards
he spread of the DON producing fungus Fusarium graminearum
nside the plant (Lemmens et al., 2005). A quantitative trait locus
esponsible for Fusarium spreading resistance, which co-localizes
ith the DON to D3G conversion capability is incorporated into
ewly released wheat cultivars worldwide (Buerstmayr et al.,
009). These (whole) plants contain up to 10 fold more D3G
han DON when treated with DON (Lemmens et al., 2005). It is
hus expected that the incorporation of this detoxiﬁcation mech-
nism into highly Fusarium susceptible cultivars will lead to an
ncrease of the D3G/DON ratio also in natural infection. A DON-
lucosyltransferase gene from barley has been recently identiﬁed
Schweiger et al., 2010), which might be utilized in transgenic
pproaches to increase Fusarium resistance by overexpression of
his gene.
Yet, the fate of D3G after digestion by mammals is largely
nknown, and the concern is that this compound may  be cleaved
o DON and glucose (reviewed by Berthiller et al., 2009b).  Another
onjugated Fusarium mycotoxin, zearalenone-14--d-glucoside
Z-14-G), was shown to produce zearalenone (ZEN) in the digestive
ract of swine (Gareis et al., 1990). This reaction was  believed to be
argely due to the activity of the gut microbiota of animals (Gareis,
994). In this work, the stability of D3G towards hydrochloric acid,
rtiﬁcial stomach juice, artiﬁcial non-microbial gut juice, a variety
f enzymes and intestinal bacteria is evaluated and discussed.
. Material and methods
.1. Chemicals and reagents
D3G was  isolated from wheat plants treated with DON at anthesis, as previously
escribed (Berthiller et al., 2005). The mycotoxin DON was  purchased from Romer
abs (Tulln, Austria) as calibrant in acetonitrile. HPLC grade methanol was  purchased
rom J.T. Baker (Deventer, The Netherlands), MS  grade ammonium acetate from
igma–Aldrich (St. Louis, MO,  USA). LC grade water was  produced with a Millipore
illi-Q plus system (Molsheim, France) after reverse osmosis. Possible hydrolysis
f  D3G to DON was  tested with the following solutions: (1) puriﬁed water; (2)ters 206 (2011) 264– 267 265
0.02 M HCl (pH approx. 1.7); (3) 0.2 M HCl (pH approx. 0.7); (4) artiﬁcial stom-
ach juice (540 mg Helo-acid, Rösch und Handel, Wien, Austria, containing pepsin,
in  0.02 M HCl); (5) artiﬁcial, non-microbial, gut juice (70 mg Kreon 40,000, Solvay
Pharma, Klosterneuburg, Austria, containing 40 mg pancreatin (4000 lipase units,
2500 amylase units, 160 protease units) in 1 g/L NaHCO3,  pH 8.0); (6) almond -
glucosidase (EC 3.2.1.21, Sigma–Aldrich G4511, 1 U/mL in 0.1 N sodium acetate
buffer, pH-value 5.0); (7) -glucuronidase (EC 3.2.1.31, isolated from Helix pomatia,
Sigma–Aldrich G7396, 10 U/mL in 0.1 N sodium acetate buffer, pH 5.0); (8) cellulase
(EC 3.2.1.4, from Trichoderma reesei, Sigma–Aldrich C8546, 1 U/mL in 0.1 N sodium
acetate buffer, pH 5.0); (9) cellobiase (EC 3.2.1.21, isolated from Aspergillus niger,
Sigma–Aldrich 49291, 130 mU/mL  in 50 mM sodium phosphate buffer containing
5  mM EDTA, pH 6.0).
2.2. Bacterial strains
The following type strains (acquired from DSMZ, Braunschweig, Germany; ATCC,
Manassas, VA, USA; LMG, Gent, Belgium) and isolates from the strain collection
of  the Department of Food Science and Technology of the University for Natu-
ral Resources and Life Sciences Vienna were used in this study: Biﬁdobacterium
adolescentis (DSM 20083, isolate B14A); Biﬁdobacterium biﬁdum (DSM 20456, iso-
lates B16A and B43A); Biﬁdobacterium longum (DSM 20219, isolates B8A and B40A);
Citrobacter freundii (isolate IMB-UE5); Enterobacter cloacae (isolate IMB-UE36); Ente-
rococcus avium (DSM 20679); Enterococcus casseliﬂavus (DSM 20680); Enterococcus
durans (DSM 20633, ATCC 6056); Enterococcus faecalis (DSM 2918, DSM 3320, DSM
6177,  DSM 20477, ATCC 27270, LMG 11733, LMG  12292, LMG  14407, LMG 15076,
LMG  16003, LMG  16196); Enterococcus faecium (LMG 16003, LMG  16196); Ente-
rococcus gallinarum (DSM 20628, DSM 20717); Enterococcus mundtii (DSM 4838);
Escherichia coli (DSM 613, DSM 30083); Lactobacillus amylovorus (DSM 20531); Lac-
tobacillus crispatus (DSM 20584, isolate L390); Lactobacillus fermentum (DSM 20052,
isolate L381); Lactobacillus gasseri (DSM 20243, isolates L357 and L421); Lactobacillus
paracasei (DSM 5622, isolates L365 and L367); Lactobacillus plantarum (DSM 20174);
and  Lactobacillus rhamnosus (DSM 20021, isolates L359 and L380).
2.3. Acidic and enzymatic hydrolysis of D3G
1 mL  aliquots of 25 mg/L stock solutions of D3G (according to 25 g pure sub-
stance) or DON (stability control) in methanol as well as of pure methanol (negative
control) were transferred into 15 mL polypropylene tubes (Sarstedt, Nümbrecht,
Germany) and evaporated to dryness at room temperature under a gentle stream of
nitrogen for each experiment. After adding 10 mL of appropriate acidic or enzymatic
solution the closed tubes were shaken for 3 h or 18 h at 30 rpm on a overhead shaker
(Labor-Brand, Gießen, Germany) in a compartment drier (Heraeus, Wien, Austria)
at 37 ◦C. 1 mL  of the incubated solutions were diluted with 1 mL methanol/water
(1/1, v/v), ﬁltered through 0.22 m Millex-GV membrane ﬁlters (Millipore, Mol-
sheim, France) and stored at −20 ◦C until analysis by LC–MS/MS. The molar amount
of  released DON was used for the calculation of the extent of hydrolysis. All reactions
were performed in triplicates.
2.4. Hydrolysis of D3G using human cytosolic ˇ-glucosidase
Recombinant human cytosolic -glucosidase (hCBG; 20 mU/mL  ﬁnal concen-
tration) was combined with 25 g D3G in a reaction volume of 100 L in 50 mM
sodium phosphate buffer pH 6.0 with 5 mM EDTA. Reactions were set up in tripli-
cate. Reactions set up with DON and enzyme or with D3G without enzyme served
as  controls. Directly after mixing, as well as after 10, 20, 30, 45, 60, 90, 120, 180 min
and 18 h at 37 ◦C, 10 l of the incubation were mixed with 90 l of ethanol. Samples
were stored at −20 ◦C until analysis by LC–MS/MS.
2.5. Incubation of D3G with bacterial suspensions
0.375 g D3G in 15 L saline magnesium buffer (100 mM NaCl, 8 mM MgSO4,
50  mM Tris–HCl, pH 7.5) were combined with 135 L of bacterial suspensions (OD600
about 2.0), giving the same concentration of 2.5 mg/L of D3G as with the enzymatic
reactions. Bacteria were incubated for 4 h and 8 h at 30 ◦C or 37 ◦C according to the
optimal growth conditions of the microbes, centrifuged at 13,000 rpm for 5 min and
300 L of ethanol were added to the supernatant. Before analysis with LC–MS/MS,
the solutions were dried under nitrogen and re-suspended in water. The amount of
released DON was used for the calculation of the extent of hydrolysis.
2.6. LC–MS/MS parameters
An 1100 Series HPLC System (Agilent, Waldbronn, Germany) in conjunction with
a  QTrap-LC–MS/MS System (Applied Biosystems, Foster City, USA) equipped with a
Turbo Ion Spray source were used for analysis. Isocratic separation of the compounds
was achieved using methanol/water (25/75, v/v) containing 5 mM ammonium
acetate, at 22 ◦C in a 100 mm × 4.6 mm,  3 m,  RP-18 Aquasil column (Thermo, Belle-
fonte, PA, USA). 10 L sample volume was injected into a ﬂow of 0.5 mL/min. The
negative ion mode was  selected for analyte ionization. ESI parameters were as fol-
lows:  source temperature 400 ◦C, curtain gas 20 psi (138 kPa), nebulizer gas 30 psi
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Table 1
Extent of hydrolysis of D3G after acidic and enzymatic treatments at 37 ◦C.
3 h 18 h
Water <0.2% <0.2%
0.02  M HCl <0.2% <0.2%
0.2  M HCl <0.2% <0.2%
Artiﬁcial stomach juice <0.2% <0.2%
Artiﬁcial gut juice <0.2% <0.2%
-Glucosidase (almond) <0.2% <0.2%
-Glucuronidase (snail) 1% 1%
Cellulase (Trichoderma) 11% 15%
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Table 2
Extent of hydrolysis of D3G after bacterial treatment.
Bacterial strain Number of strains 4 h 8 h
Biﬁdobacterium adolescentis 2 5–17% 17–25%
Biﬁdobacterium biﬁdum 3 <0.2% <0.2%
Biﬁdobacterium longum 3 <0.2% <0.2%
Citrobacter freundii 1 <0.2% <0.2%
Enterobacter cloacae 1 17% 25%
Enterococcus avium 1 <0.2% <0.2%
Enterococcus casseliﬂavus 1 5% 8%
Enterococcus durans 2 8–16% 14–27%
Enterococcus faecalis 2 <0.2–3% <0.2–3%
Enterococcus faecium 11 4–39% 6–55%
Enterococcus gallinarum 2 <0.2–2% 1–3%
Enterococcus mundtii 1 18% 38%
Escherichia coli 2 <0.2% <0.2%
Lactobacillus amylovorus 1 <0.2% <0.2%
Lactobacillus crispatus 2 <0.2% <0.2%
Lactobacillus fermentum 2 <0.2% <0.2%
Lactobacillus gasseri 3 <0.2% <0.2%
Lactobacillus paracasei 3 <0.2% <0.2%Cellobiase (Aspergillus) 60% 73%
-Glucosidase (human) <0.2% <0.2%
207 kPa), auxiliary gas 75 psi (517 kPa), ion spray voltage −4200 V, CAD gas 6 (arbi-
rary units), MRM dwell time 50 ms,  pause between mass ranges 5 ms.  The MRM
ransition of m/z 517.1 to m/z 59.1 (DP −32 V, CE −81 eV) was chosen for D3G, while
/z 355.1 to m/z 59.1 (DP −16 V, CE −30 eV) was chosen for DON. Qualiﬁer transitions
ere taken from the original LC–MS/MS method (Berthiller et al., 2005).
. Results
In order to determine the fate of D3G upon ingestion by mam-
als, in vitro experiments mimicking the digestion conditions in
he gastrointestinal tract were performed. Control experiments
roved the stability of the precursor mycotoxin, DON, at all inves-
igated conditions. Furthermore, the sum of the molar amount of
ON and D3G remained roughly constant (within 10%) in all exper-
ments, indicating no losses of toxins during the experiments.
.1. Acidic hydrolysis of D3G
Acidic solutions were used to assess the impact of the conditions
ound in the stomach of mammals on D3G stability. D3G proved to
e completely stable towards acid hydrolysis with 0.02 M HCl, at
 pH-value of about 1.7, which is at the lower end of the stomach
H range in humans. Even at a 10 times higher concentration of
Cl, at a pH-value of about 0.7, no DON could be detected after
ncubation of D3G at 37 ◦C for 3 h or 18 h. Artiﬁcial stomach juice,
ontaining pepsin at pH 1.7, also had no effect on D3G. The results
f the hydrolysis studies under acidic and enzymatic conditions
see below) are summarized in Table 1. In all acid-treated samples
00 ± 2% of D3G were recovered.
.2. Enzymatic hydrolysis of D3G
A variety of glycosylhydrolases was used to test the enzymatic
tability of D3G. Artiﬁcial (non-microbial) gut juice, containing
mylase, showed no activity at all towards the -glucoside D3G.
imilarly, while testing 1 U/mL of almond -glucosidase, no activity
<0.01 mg  DON/L) was noticed towards D3G. This is in agree-
ent with results obtained previously for D3G (Sewald et al.,
992) while Z-14-G was completely converted to ZEN (although at
igher enzyme concentrations) by this enzyme (Gareis et al., 1990).
ore importantly, also human cytosolic -glucosidase (hCBG,
xpressed in Pichia pastoris) did not show any activity for D3G.
-Glucuronidase, commercially puriﬁed from snail gut, can cleave
-glucuronides, but also possesses high -glucosidase and aryl-
ulfatase side activities. At the given conditions using 10 U/mL of
-glucuronidase, just a minimal DON peak (about 1%) was  obtained
fter treating D3G. Finally, experiments were carried out using
ellulase, which cleaves -glucosidic bonds of cellulose. Partial
leavage of D3G to DON (about 11% after 3 h, about 15% after 18 h)
as observed after cellulase treatment. We  suspect this activity is
ue to co-occurrence of -glucosidases (cellobiase) from Tricho-
erma,  rather than to a side activity of an endo- or exo-cellulase.
his is in good agreement with the results gained using AspergillusLactobacillus plantarum 1 34% 62%
Lactobacillus rhamnosus 3 <0.2% <0.2%
cellobiase, which yielded the highest conversion of about 60% after
3 h and 73% after 18 h.
3.3. Hydrolysis of D3G by bacteria
Forty-seven different bacterial strains, isolated from guts, were
examined towards their ability to hydrolyze D3G. B. biﬁdum, B.
longum, C. freundii, E. avium,  E. coli, L. amylovorus, L. crispatus, L.
fermentum, L. gasseri,  L. paracasei and L. rhamnosus showed no activ-
ity. E. casseliﬂavus, E. faecalis, and E. gallinarum liberated minor
amounts of DON (1–8% after 8 h) from D3G. However, E. cloacae,
E. durans,  E. faecium, E. mundtii but also L. plantarum and B. ado-
lescentis efﬁciently cleaved D3G, releasing up to 62% DON after 8 h
(Table 2).
4. Discussion
Up to now, data regarding the toxicological relevance of D3G
were lacking. Our results indicate that D3G is resistant to acidic
conditions. It is, therefore, extremely unlikely that D3G can be
hydrolyzed into DON in the stomach of mammals. Pretty much the
same results were gained using digestive enzymes in vitro, sug-
gesting that D3G will most likely pass unchanged also through
the small intestine. For instance amylase, which is produced in
the salivary glands and the pancreas and able to cleave the -
glucosidic bonds of starch, showed no potential to hydrolyze D3G.
-Glucosidase is expressed in human liver, kidney, spleen and gut
(Berrin et al., 2002) and plays an important role in the hydrolysis
of plant glucosides like ﬂavones, isoﬂavones, ﬂavanones, ﬂavonoles
or cyanogenic glucosides like amygdalin. However, there are sev-
eral naturally occurring glucosides that cannot be cleaved by hCBG,
including D3G. The position of the glucose in the molecule is
of importance as, e.g. quercetin-7-glucoside can be cleaved by
hCBG in contrast to quercetin-3-glucoside (Berrin et al., 2002). -
Glucuronidase can be found in human plasma and at high levels
also in the placenta. The available snail -glucuronidase showed
virtually no hydrolytic activity towards D3G. Therefore, the snail
gut -glucuronidase enzyme mixture, which is frequently used to
liberate DON from DON-glucuronic acid conjugates in urine and
other tissue samples is unsuitable for hydrolysis of D3G in grain
samples for analytical purposes. While enzymes encoded by the
human genome seem to be of no relevance, microbial inhabitants
of the intestines are providing a rich source of hydrolytic enzymes.
Cellulase is produced by a variety of microorganisms found in the
gy Let
g
a
s
c
u
t
s
B
s
d
(
u
l
i
c
s
p
T
o
D
g
e
b
p
d
m
T
d
d
b
h
i
p
a
m
t
s
t
t
m
t
C
A
p
t
N
g
f
R
A
BF. Berthiller et al. / Toxicolo
ut of ruminants. Since the fungal cellulase and in particular cellobi-
se preparations used in this study could hydrolyze D3G, it might be
peculated that D3G is cleaved and DON is released by plant-based
ellulose-foraging ruminants.
Our results clearly show that under the in vitro conditions
sed in this study, D3G was converted to DON upon incuba-
ion with several pure cultures of intestinal bacteria, in particular
pecies of the genera Lactobacillus, Enterococcus, Enterobacter and
iﬁdobacterium. Only partial hydrolysis was obtained under the
emi-aerobic conditions used in this work whereas anaerobic con-
itions prevail in the mammalian gut. The D3G concentration
corresponding to 2.5 mg/L) used in incubations with bacteria is
nrealistically high for food, but not for feed samples, where guide-
ine levels for DON are as high as 12 mg/kg. The bacterial density
n the gut is signiﬁcantly higher than in our in vitro tests; however
omplex mixtures and matrix inﬂuences are occurring. The den-
ity of bacteria in faeces is about 1012 cfu/g, while the densities of
ure cultures used in our study correspond to about 109 cfu/mL.
his suggests that even species that contribute only few percent
f the microbiota may  release a signiﬁcant portion of DON from
3G in the lower gastrointestinal tract. Glucoside hydrolases/-
lucosidases are overrepresented in gut metagenome studies (Gill
t al., 2006), thus enzymes with speciﬁcity for D3G are expected to
e abundant. A highly relevant factor seems to be the species com-
osition of the intestinal microbiota. Due to microbial diversity and
ensity, different cleavage rates can be expected in different ani-
als or humans (Abbott, 2004). Metagenome studies (Hattori and
aylor, 2009) indicate that there are also clear trends towards a
ifferent composition between adults and infants. For instance, Biﬁ-
obacterium and Lactobacillus species are more abundant in infants.
Taken together this in vitro study suggests that DON detoxiﬁed
y the plant into D3G may  become partly bioavailable due to D3G
ydrolysis by bacterial -glucosidases in the colon. Yet, it seems
mpossible to predict to which extent hydrolysis occurs in a given
erson. Beside an individual microbiota, D3G hydrolysis may  be
lso highly dependent on other factors, such as the kind of fer-
ented milk products or abundant probiotic bacteria consumed
ogether with D3G contaminated cereal products. If, as our data
uggest, most of the present D3G is hydrolyzed to the parental
oxin, D3G is of toxicological relevance and should be monitored
ogether with DON in cereals, especially since the portion of the
asked toxin might increase in the future due to Fusarium resis-
ance breeding efforts.
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